Results of low dose helical arc intensive modulated radiotherapy (IMRT) in brain metastases localized in brainstem
JOURNAL OF RADIATION ONCOLOGY AND PALLIATION · 2024
DOI: 10.29228/jrop.87999 ↗Kurz gefasst
Fachartikel in der Zeitschrift JOURNAL OF RADIATION ONCOLOGY AND PALLIATION, 2024. Verfasst von Kimia ÇEPNİ.
Abstract (Originalsprache)
Brainstem localized metastases (BSM) are rare compared to other brain metastases. BSM are associated with a poor prognosis and their management represents a therapeutic challenge. These patients have more complaints, treatment is difficult, and treatment related side effects are more. Radiotherapy (RT) is the primary palliative treatment that can be applied rather than surgery or chemotherapy. Side effects are severe in patients who are treated with high dose RT and the treatment of many patients is left unfinished due to neurological morbidities. We reviewed the literature and the patients’ outcomes at our center for those who have metastases localized in brainstem and were treated with conventional fractionation and lower doses than standard.
Zitieren
APA
ÇEPNİ, K. (2024). Results of low dose helical arc intensive modulated radiotherapy (IMRT) in brain metastases localized in brainstem. JOURNAL OF RADIATION ONCOLOGY AND PALLIATION. https://doi.org/10.29228/jrop.87999
Vancouver
ÇEPNİ K. Results of low dose helical arc intensive modulated radiotherapy (IMRT) in brain metastases localized in brainstem. JOURNAL OF RADIATION ONCOLOGY AND PALLIATION. 2024. doi:10.29228/jrop.87999
BibTeX
@article{EPN2024,
author = {ÇEPNİ, Kimia},
title = {Results of low dose helical arc intensive modulated radiotherapy (IMRT) in brain metastases localized in brainstem},
journal = {JOURNAL OF RADIATION ONCOLOGY AND PALLIATION},
year = {2024},
doi = {10.29228/jrop.87999}
}
EUVIMED